by Joel Rothman | Sep 27, 2009 | NutriSupLaw
Let us start by apologizing to the Bard and my 8th grade English teacher for the headline. It’s a good way to ask the question of how closely nutritional supplement companies can connect with the fast-moving world of social media. Should you Tweet about a new...
by Joel Rothman | Aug 31, 2009 | NutriSupLaw
This is a tale of two types of weight-loss products and how the Food and Drug Administration had different responses to similar problems with them. The separate, but not equivalent treatment raises questions about how the FDA operates. On Aug. 24, the FDA issued a...
by Joel Rothman | May 27, 2009 | NutriSupLaw
In the days following the FDA warning on the dangers of taking Hydroxycut and the manufacturer’s recall, the reaction has been more sliced than divided. There were the oft-seen reactions: NaturalNews headlined its commentary, “FDA Floats Hydroxycut Scare...
by Joel Rothman | Mar 26, 2009 | NutriSupLaw
When it comes to dietary supplements, it’s like the Wild West, and the bad guys know they don’t have to take the sheriff seriously. Industry and consumer voices are split in their interpretations of a GAO report on how the FDA should regulate dietary...
by Joel Rothman | Dec 13, 2008 | NutriSupLaw
Although Section 403(y) of the Federal Food, Drug, and Cosmetic Act (FFD&C Act) (21 U.S.C. 343(y), does not require a dietary supplement label to include anything other than a domestic address or phone number for the responsible person, the FDA recommends that the...
